Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

301.26
Delayed Data
As of 11:34am ET
 +1.10 / +0.37%
Today’s Change
13.10
Today|||52-Week Range
325.98
+228.21%
Year-to-Date

Today’s Trading

Previous close300.16
Today’s open298.18
Day’s range298.12 - 307.81
Volume72,099
Average volume (3 months)372,697
Market cap$1.8B
Data as of 11:34am ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+49.90%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book10.13

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.06-0.74%
STMLStemline Therapeutic...-0.20-1.12%
ZYMEZymeworks Inc+0.12+0.71%
NEOSNeos Therapeutics In...-0.03-0.46%
Data as of 11:36am ET, 06/18/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$0.00
Annual profit (last year)-$31.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Paul A. Friedman
CFO, Principal Accounting Officer &
Senior VP
Marc R. Schneebaum
Corporate headquarters
West Conshohocken, Pennsylvania

Forecasts